KOSDAQ - Delayed Quote KRW
Sam-A Pharm. Co., Ltd (009300.KQ)
17,130.00
-140.00
(-0.81%)
At close: 3:30:30 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
95,580,725.36
95,580,725.36
97,211,286.21
81,699,539.72
54,666,374.87
Cost of Revenue
34,752,253.66
34,752,253.66
35,587,254.05
31,536,919.80
22,008,555.72
Gross Profit
60,828,471.70
60,828,471.70
61,624,032.16
50,162,619.92
32,657,819.15
Operating Expense
36,362,006
36,362,006
38,123,822
31,909,436
26,609,605
Operating Income
24,466,465.70
24,466,465.70
23,500,210.16
18,253,183.92
6,048,214.15
Net Non Operating Interest Income Expense
4,926,554.42
4,926,554.42
4,424,081.12
2,368,211.11
1,377,195.92
Pretax Income
29,269,929.54
29,269,929.54
28,475,587.51
18,400,109.51
5,334,940.43
Tax Provision
7,190,355.14
7,190,355.14
7,101,651.94
6,488,496.98
1,943,412.29
Net Income Common Stockholders
22,079,574.39
22,079,574.39
21,373,935.57
11,911,612.53
3,391,528.14
Basic EPS
3.62k
--
3.50k
1.95k
556.00
Diluted EPS
3.62k
--
3.50k
1.95k
556.00
Basic Average Shares
6,102.70
--
6,103.35
6,102.26
6,099.87
Diluted Average Shares
6,102.70
--
6,103.35
6,102.26
6,099.87
Total Operating Income as Reported
24,466,466.16
24,466,466.16
23,500,211.53
18,253,183.86
6,048,214.63
Rent Expense Supplemental
89,677
89,677
302,339
672,257
343,715
Total Expenses
71,114,259.66
71,114,259.66
73,711,076.05
63,446,355.80
48,618,160.72
Net Income from Continuing & Discontinued Operation
22,079,574.39
22,079,574.39
21,373,935.57
11,911,612.53
3,391,528.14
Normalized Income
21,790,419.53
21,790,419.53
20,565,625.66
12,773,565.35
3,382,464.68
Interest Income
5,464,774
5,464,774
4,643,818
2,431,640
1,502,810
Interest Expense
538,220
538,220
219,737
63,429
125,615
Net Interest Income
4,926,554.42
4,926,554.42
4,424,081.12
2,368,211.11
1,377,195.92
EBIT
29,808,149.54
29,808,149.54
28,695,324.51
18,463,538.51
5,460,555.43
EBITDA
34,074,614.54
34,074,614.54
32,590,425.51
21,650,580.51
9,159,691.43
Reconciled Cost of Revenue
34,752,253.66
34,752,253.66
35,587,254.05
31,536,919.80
22,008,555.72
Reconciled Depreciation
4,266,465
4,266,465
3,895,101
3,187,042
3,699,136
Net Income from Continuing Operation Net Minority Interest
22,079,574.39
22,079,574.39
21,373,935.57
11,911,612.53
3,391,528.14
Total Unusual Items Excluding Goodwill
383,320
383,320
1,076,877
-1,331,476
14,257
Total Unusual Items
383,320
383,320
1,076,877
-1,331,476
14,257
Normalized EBITDA
33,691,294.54
33,691,294.54
31,513,548.51
22,982,056.51
9,145,434.43
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
94,165.14
94,165.14
268,567.09
-469,523.18
5,193.54
12/31/2021 - 9/14/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade